Spartan Energy Files for $400 Million SPAC Backed by Apollo
Breaking news: Spartan Energy Acquisition Corp. files for a $400 million SPAC, backed by Apollo as Sponsor, Underwriter and Forward Purchaser. Plus, Citigroup is back in the game for 2018 with another energy SPAC, and back in a big way on the left of the cover.
I’m currently going through the filing and will report back with details as soon as I’ve had a chance to read through the entire document. However, there were two other filings tonight as well: Tenzing Acquisition Corp. (profile here) and Megalith Financial Acquisition Corp. (profile here). The Megalith name is…questionable…and frankly, reminds me of a certain Michael Bay movie. Next up, the Optimus Prime SPAC?
All told, three new SPACs on a Friday evening jibes right with my predictions….late July filings to tee up the fall calendar. Expect more in the next two weeks.
Stay tuned for more details.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...